WaveClear
Strives to create the most effective and least intrusive treatments for vascular diseases.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
$1.1m | Series A | ||
| Total Funding | 000k | ||
Related Content
WaveClear is a pioneering medical technology company specializing in the development of ultrasonic solutions for the treatment of vascular diseases. Utilizing the piezoelectric effect, WaveClear's CaviClear technology generates ultrasonic energy in wires to clear partial and total occlusions in peripheral arteries. The company's core product aims to provide the most effective and least intrusive treatments for vascular conditions, thereby improving patient outcomes and reducing recovery times.
WaveClear primarily serves healthcare providers, including hospitals and specialized vascular treatment centers. Operating in the medical technology market, the company leverages a business-to-business (B2B) model. Revenue is generated through the sale of its proprietary ultrasonic devices and related services, including maintenance and training for medical professionals.
Founded by Jeffrey Vaitekunas, a seasoned expert in therapeutic medical ultrasound with over 25 patents, WaveClear has garnered significant attention and investment, including a $1.125 million Series A funding led by Hunniwell Lake Ventures. The company continues to innovate in the field of medical ultrasound, aiming to set new standards in vascular treatment.
Keywords: ultrasonic technology, vascular occlusions, piezoelectric effect, CaviClear, peripheral arteries, medical devices, healthcare providers, B2B, vascular treatment, Series A funding.